A recent study based on bioinformatics and immunohistochemistry suggested that dysregulation of DPP4 expression in AML severely affects chemotherapy sensitivity, yet the mechanisms involved are unclear (Wei et al., 2021). The gene discussed is DPP4; the disease is acute myeloid leukemia.